Last reviewed · How we verify
ALX-0600
At a glance
| Generic name | ALX-0600 |
|---|---|
| Also known as | GATTEX |
| Sponsor | Shire |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study of Teduglutide in Chinese Children and Teenagers With Short Bowel Syndrome
- TED_ORG: Study on Short Bowel Syndrome (NA)
- A Survey to Assess Participants' and Physicians' Knowledge When Using GATTEX (Knowledge Assessment Survey)
- Registry for Participants With Short Bowel Syndrome
- Characterization of the Long-term Safety, Efficacy, and Pharmacodynamics Revestive® in the Management of Short Bowel Syndrome Pediatric Patients (PHASE4)
- A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome (PHASE3)
- A Study of Teduglutide in Japanese People With Short Bowel Syndrome
- A Study of Teduglutide (Revestive®) in Participants With Short Bowel Syndrome (SBS) in Canada
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |